Wei‐Xiang Qi
Impact in
- Oncology top 2%
- Cancer Treatment and Pharmacology
- Bone health and treatments
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
-
- Lung Cancer Treatments and Mutations
- Gastric Cancer Management and Outcomes
Papers in
- Oncology 62
- Colorectal Cancer Treatments and Studies 15
- Cancer Treatment and Pharmacology 12
- HER2/EGFR in Cancer Research 11
- Lung Cancer Research Studies 11
-
- Lung Cancer Treatments and Mutations 21
- Gastric Cancer Management and Outcomes 13
Wei‐Xiang Qi
99 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 95
- Oncology 1.1k
- Pulmonary and Respiratory Medicine 940
- Internal Medicine 74
- Hepatology 142
- Orthopedics and Sports Medicine 149
Countries citing papers authored by Wei‐Xiang Qi
This map shows the geographic impact of Wei‐Xiang Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Xiang Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Xiang Qi more than expected).
Fields of papers citing papers by Wei‐Xiang Qi
This network shows the impact of papers produced by Wei‐Xiang Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Xiang Qi. The network helps show where Wei‐Xiang Qi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wei‐Xiang Qi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 0 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 0 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 9 | |
| 11 | 2022 | 4 | |
| 12 | 2022 | 5 | |
| 13 | 2021 | 2 | |
| 14 | 2015 | 23 | |
| 15 | 2013 | 8 | |
| 16 | 2013 | 37 | |
| 17 | 2013 | 28 | |
| 18 | 2012 | 41 | |
| 19 | 2012 | 45 | |
| 20 | COX proportional-hazard regression analysis of prognostic factors in 52 adult patients with osteosarcoma | 2011 | 1 |
About Wei‐Xiang Qi
Wei‐Xiang Qi is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Pathology and Forensic Medicine and Hepatology, having authored 109 papers that have together received 2.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (21 papers), Breast Cancer Treatment Studies (18 papers), Colorectal Cancer Treatments and Studies (15 papers), Gastric Cancer Management and Outcomes (13 papers), Cancer Treatment and Pharmacology (12 papers), HER2/EGFR in Cancer Research (11 papers), Lung Cancer Research Studies (11 papers) and Esophageal Cancer Research and Treatment (10 papers). The work is most often cited by research in Oncology (1.1k citations), Pulmonary and Respiratory Medicine (940 citations), Internal Medicine (74 citations), Hepatology (142 citations) and Orthopedics and Sports Medicine (149 citations). Wei‐Xiang Qi has collaborated with scholars based in China, United States and France. Frequent co-authors include Zan Shen, Yang Yao, Lina Tang, Aina He, Yuanjue Sun, Feng Lin, Shen Fu, Xiaomao Guo, Daliu Min and Yang Yao. Their work appears in journals such as Frontiers in Oncology, International Journal of Radiation Oncology*Biology*Physics, Annals of Oncology, Current Medical Research and Opinion and British Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.